$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
Insider Buying This Major Airline Stock; 3 Stocks Insiders Are Buying
12:37pm, Monday, 18'th Jul 2022 Benzinga
Although US stocks closed higher on Friday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock
How to Find Penny Stocks to Buy in Summer 2022
03:30pm, Saturday, 16'th Jul 2022 PennyStocks
Use these tips to find penny stocks to buy this Summer
The post How to Find Penny Stocks to Buy in Summer 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
How to Find Penny Stocks to Buy in Summer 2022
11:30am, Saturday, 16'th Jul 2022
Use these tips to find penny stocks to buy this Summer The post How to Find Penny Stocks to Buy in Summer 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
09:20am, Friday, 15'th Jul 2022 Benzinga
Gainers
Clene Inc. (NASDAQ: CLNN) shares jumped 43.4% to close at $4.13. Clene reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
09:58am, Thursday, 14'th Jul 2022 Benzinga
Gainers
Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Liberty TripAdvisor Holdings
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
04:21pm, Wednesday, 13'th Jul 2022 Benzinga
Gainers
Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
ironSource Ltd. (NYSE: IS) gained 48.
Wall Street Analysts Believe Gossamer Bio (GOSS) Could Rally 113%: Here's is How to Trade
01:55pm, Thursday, 26'th May 2022 Zacks Investment Research
The mean of analysts' price targets for Gossamer Bio (GOSS) points to an 113.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among a
Gossamer Bio (GOSS) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
01:55pm, Monday, 23'rd May 2022 Zacks Investment Research
After losing some value lately, a hammer chart pattern has been formed for Gossamer Bio (GOSS), indicating that the stock has found support. This, combined with an upward trend in earnings estimate re
Where Gossamer Bio Stands With Analysts
04:08pm, Tuesday, 26'th Apr 2022 Benzinga
Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
0
0
0
La
Gossamer Bio Pulls Plug On Mid-Stage Ulcerative Colitis Program
09:06am, Monday, 25'th Apr 2022
Gossamer Bio Inc (NASDAQ: GOSS) shares are falling after announcing topline results from its Phase 2 SHIFT-UC Study trial of GB004 in patients with mild-to-moderate active ulcerative colitis (UC).
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022
02:04pm, Monday, 18'th Apr 2022 Benzinga
Upgrades
For PBF Energy Inc (NYSE:PBF), Scotiabank upgraded the previous rating of Sector Underperform to Sector Perform. For the fourth quarter, PBF Energy had an EPS of $1.28, compared to year-ago q
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades
According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c
Gossamer Bio GAAP EPS of -$0.74 misses by $0.02
10:34pm, Thursday, 03'rd Mar 2022 Seeking Alpha
Gossamer Bio press release (GOSS): Q4 GAAP EPS of -$0.74 misses by $0.02.Cash, cash equivalents and marketable securities totaled $325 million at year-end 2021.
Gossamer Bio files for mixed shelf offering
10:12pm, Thursday, 03'rd Mar 2022 Seeking Alpha
Gossamer Bio (GOSS) has filed for a mixed shelf offering of a yet to be determined amount.
Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update
09:01pm, Thursday, 03'rd Mar 2022 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the fourth quarter and year ended December 31, 2021 and provided a business update. “After a considerable amount of planning and effort, the Gossamer team is excited to enter 2022 with two ongoing Phase 2 tria
Sign In
Buy GOSS